Cerebral Oxygenation during Different Treatment Strategies for a Patent Ductus ArteriosusChock V.Y.a · Ramamoorthy C.b · Van Meurs K.P.a
aDivision of Neonatal and Developmental Medicine, Department of Pediatrics, and bDivision of Pediatric Anesthesia, Department of Anesthesia, Stanford University School of Medicine and Lucile Packard Children’s Hospital, Palo Alto, Calif., USA
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Preterm infants with a hemodynamically significant patent ductus arteriosus (hsPDA) are at risk for fluctuations in cerebral blood flow, but it is unclear how different hsPDA treatment strategies may affect cerebral oxygenation. Objective: To compare regional cerebral oxygen saturation (rSO2) as measured by near-infrared spectroscopy (NIRS) in very low birth weight (VLBW) infants with a hsPDA treated with conservative management, indomethacin, or surgical ligation. Methods: This prospective observational study enrolled 33 VLBW infants with a hsPDA diagnosed by echocardiogram and 12 control VLBW infants without a hsPDA. Infants had NIRS cerebral monitoring applied prior to conservative treatment, indomethacin, or surgical ligation. Cranial ultrasound and magnetic resonance imaging data were also collected. Results: Infants undergoing surgical ligation had a greater time period with >20% change in rSO2 from baseline (30%) compared to those receiving indomethacin (7.4%, p = 0.001) or control infants without a hsPDA (2.6%, p = 0.0004). NIRS measures were not associated with abnormal neuroimaging in this small cohort. Conclusion:These findings suggest that infants requiring surgical ligation for a hsPDA are at high risk for significant changes in cerebral oxygenation, whereas those receiving either indomethacin or conservative management maintain relatively stable cerebral oxygenation levels. Additional research is necessary to determine if NIRS monitoring identifies infants with a hsPDA at highest risk for brain injury.
© 2011 S. Karger AG, Basel
- Meier SD, Eble BK, Stapleton GE, Morales DL, Chang AC, Andropoulos DB: Mesenteric oxyhemoglobin desaturation improves with patent ductus arteriosus ligation. J Perinatol 2006;26:562–564.
- Rais-Bahrami K, Rivera O, Short BL: Validation of a noninvasive neonatal optical cerebral oximeter in veno-venous ECMO patients with a cephalad catheter. J Perinatol 2006;26:628–635.
- Menke J, Voss U, Moller G, Jorch G: Reproducibility of cerebral near-infrared spectroscopy in neonates. Biol Neonate 2003;83:6–11.
- Lemmers PM, Toet MC, van Bel F: Impact of patent ductus arteriosus and subsequent therapy with indomethacin on cerebral oxygenation in preterm infants. Pediatrics 2008;121:142–147.
- Evans N, Kluckow M: Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;75:F183–F186.
- Miller SP, Mayer EE, Clyman RI, Glidden DV, Hamrick SE, Barkovich AJ: Prolonged indomethacin exposure is associated with decreased white matter injury detected with magnetic resonance imaging in premature newborns at 24 to 28 weeks’ gestation at birth. Pediatrics 2006;117:1626–1631.
- Ment LR, Oh W, Ehrenkranz RA, Philip AG, Vohr B, Allan W, Duncan CC, Scott DT, Taylor KJ, Katz KH, et al.: Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial. Pediatrics 1994;93:543–550.
- Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL: Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966–1972.
- Vanhaesebrouck S, Zonnenberg I, Vandervoort P, Bruneel E, Van Hoestenberghe MR, Theyskens C: Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed 2007;92:F244–F247.
- Lee BS, Byun SY, Chung ML, Chang JY, Kim HY, Kim EA, Kim KS, Pi SY: Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period. Neonatology 2010;98:191–199.
- Kabra NS, Schmidt B, Roberts RS, Doyle LW, Papile L, Fanaroff A: Neurosensory impairment after surgical closure of patent ductus arteriosus in extremely low birth weight infants: results from the Trial of Indomethacin Prophylaxis in Preterms. J Pediatr 2007;150:229–234, 234.e1.
- Chorne N, Leonard C, Piecuch R, Clyman RI: Patent ductus arteriosus and its treatment as risk factors for neonatal and neurodevelopmental morbidity. Pediatrics 2007;119:1165–1174.
- Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD: Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000;47:36–42.
- Zaramella P, Freato F, Quaresima V, Ferrari M, Bartocci M, Rubino M, Falcon E, Chiandetti L: Surgical closure of patent ductus arteriosus reduces the cerebral tissue oxygenation index in preterm infants: a near-infrared spectroscopy and Doppler study. Pediatr Int 2006;48:305–312.
- Vanderhaegen J, De Smet D, Meyns B, Van De Velde M, Van Huffel S, Naulaers G: Surgical closure of the patent ductus arteriosus and its effect on the cerebral tissue oxygenation. Acta Paediatr 2008;97:1640–1644.
- Austin EH 3rd, Edmonds HL Jr, Auden SM, Seremet V, Niznik G, Sehic A, Sowell MK, Cheppo CD, Corlett KM: Benefit of neurophysiologic monitoring for pediatric cardiac surgery. J Thorac Cardiovasc Surg 1997;114:707–717.
- Kurth CD, Steven JM, Nicolson SC, Chance B, Delivoria-Papadopoulos M: Kinetics of cerebral deoxygenation during deep hypothermic circulatory arrest in neonates. Anesthesiology 1992;77:656–661.
- Richardson DK, Corcoran JD, Escobar GJ, Lee SK: SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr 2001;138:92–100.
- Naulaers G, Meyns B, Miserez M, Leunens V, Van Huffel S, Casaer P, Weindling M, Devlieger H: Use of tissue oxygenation index and fractional tissue oxygen extraction as non-invasive parameters for cerebral oxygenation. A validation study in piglets. Neonatology 2007;92:120–126.
- Benders MJ, Dorrepaal CA, van de Bor M, van Bel F: Acute effects of indomethacin on cerebral hemodynamics and oxygenation. Biol Neonate 1995;68:91–99.
- Keating P, Verhagen E, van Hoften J, ter Horst H, Bos AF: Effect of indomethacin infused over 30 minutes on cerebral fractional tissue oxygen extraction in preterm newborns with a patent ductus arteriosus. Neonatology 2010;98:232–237.
- Hammerman C, Glaser J, Schimmel MS, Ferber B, Kaplan M, Eidelman AI: Continuous versus multiple rapid infusions of indomethacin: effects on cerebral blood flow velocity. Pediatrics 1995;95:244–248.
- Madan JC, Kendrick D, Hagadorn JI, Frantz ID 3rd: Patent ductus arteriosus therapy: impact on neonatal and 18-month outcome. Pediatrics 2009;123:674–681.
- Lundell BP, Sonesson SE, Cotton RB: Ductus closure in preterm infants. Effects on cerebral hemodynamics. Acta Paediatr Scand Suppl 1986;329:140–147.
- Lemmers PM, Molenschot MC, Evens J, Toet MC, van Bel F: Is cerebral oxygen supply compromised in preterm infants undergoing surgical closure for patent ductus arteriosus? Arch Dis Child Fetal Neonatal Ed 2010;95:F429–F434.
- Sonesson SE, Lundell BP, Herin P: Changes in intracranial arterial blood flow velocities during surgical ligation of the patent ductus arteriosus. Acta Paediatr Scand 1986;75:36–42.
- Huning BM, Asfour B, Konig S, Hess N, Roll C: Cerebral blood volume changes during closure by surgery of patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2008;93:F261–F264.
- McNamara PJ, Stewart L, Shivananda SP, Stephens D, Sehgal A: Patent ductus arteriosus ligation is associated with impaired left ventricular systolic performance in premature infants weighing less than 1,000 g. J Thorac Cardiovasc Surg 2010;140:150–157.
- Noori S, Friedlich P, Seri I, Wong P: Changes in myocardial function and hemodynamics after ligation of the ductus arteriosus in preterm infants. J Pediatr 2007;150:597–602.
- Hamon I, Hascoet JM, Debbiche A, Vert P: Effects of fentanyl administration on general and cerebral haemodynamics in sick newborn infants. Acta Paediatr 1996;85:361–365.
- The Victorian Infant Collaborative Study Group: Surgery and the tiny baby: sensorineural outcome at 5 years of age. J Paediatr Child Health 1996;32:167–172.
- O’Leary H, Gregas MC, Limperopoulos C, Zaretskaya I, Bassan H, Soul JS, Di Salvo DN, du Plessis AJ: Elevated cerebral pressure passivity is associated with prematurity-related intracranial hemorrhage. Pediatrics 2009;124:302–309.
- Soul JS, Hammer PE, Tsuji M, Saul JP, Bassan H, Limperopoulos C, Disalvo DN, Moore M, Akins P, Ringer S, Volpe JJ, Trachtenberg F, du Plessis AJ: Fluctuating pressure-passivity is common in the cerebral circulation of sick premature infants. Pediatr Res 2007;61:467–473.
- Dammann O, Leviton A, Gappa M, Dammann CE: Lung and brain damage in preterm newborns, and their association with gestational age, prematurity subgroup, infection/inflammation and long term outcome. BJOG 2005;112(suppl 1):4–9.
- Levene MI, Shortland D, Gibson N, Evans DH: Carbon dioxide reactivity of the cerebral circulation in extremely premature infants: effects of postnatal age and indomethacin. Pediatr Res 1988;24:175–179.
- Low JA, Froese AB, Galbraith RS, Smith JT, Sauerbrei EE, Derrick EJ: The association between preterm newborn hypotension and hypoxemia and outcome during the first year. Acta Paediatr 1993;82:433–437.
- Fanaroff JM, Wilson-Costello DE, Newman NS, Montpetite MM, Fanaroff AA: Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants. Pediatrics 2006;117:1131–1135.
- Zhang J, Penny DJ, Kim NS, Yu VY, Smolich JJ: Mechanisms of blood pressure increase induced by dopamine in hypotensive preterm neonates. Arch Dis Child Fetal Neonatal Ed 1999;81:F99–F104.
- Pellicer A, Valverde E, Elorza MD, Madero R, Gaya F, Quero J, Cabanas F: Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial. Pediatrics 2005;115:1501–1512.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.